Cancer Treatment and Surgery in India: A Complete Guide for Patients from Bangladesh

Author:- Dr. Dheeraj Bojwani Date Created:- 12-08-2026

What a Bangladeshi patient and their family should know before choosing a hospital, city and care team across the border — costs, process and the questions worth asking before you book a ticket. Cancer in Bangladesh does not always follow the pattern most awareness campaigns are built around. A 2025 hospital-based case-control study from Dhaka found smokeless tobacco use — chewing betel quid, often combined with zarda or gul — was strongly linked to oral cancer, with the risk found to be substantially higher in women than in men. This runs against the common assumption that oral cancer is mainly a smoker's disease affecting men; in Bangladesh, a habit widely seen as an everyday social custom, shared at gatherings and after meals, is quietly driving one of the country's more common and treatable cancers, often diagnosed late because it is not recognised as a health risk in the first place. This guide sets out what cancer treatment and surgery in India actually involves, what it realistically costs compared with the UK and US, and the practical decisions that separate a smooth trip from a stressful one.

Healing Journeys of Bangladeshi Patients

Bangladeshi Patients Share Their Experience

Key Takeaways

• The guide explains that cancer treatment is rarely limited to surgery alone. Depending on the cancer type, stage and tumour biology, Bangladeshi patients may require surgery, radiotherapy, chemotherapy, targeted therapy or immunotherapy, with multidisciplinary tumour-board review helping determine the appropriate treatment sequence.
• Oral cancer is an important regional concern for Bangladesh. The guide highlights betel quid and smokeless tobacco use, including products such as zarda or gul, as important risk factors associated with oral cancer. Persistent mouth ulcers, white or red patches and ongoing soreness should therefore receive specialist evaluation rather than being assumed to be harmless.
• Reconstructive surgery can be an important part of oral and head-and-neck cancer treatment. The guide stresses that removing the tumour is only part of the surgical outcome. Patients should also discuss reconstruction and how treatment may affect appearance, eating and speech before the operation is planned.
• Multidisciplinary tumour-board review is a key consideration when choosing an Indian cancer centre. Bangladeshi patients should confirm that surgical oncology, medical oncology, radiation oncology and pathology specialists can jointly review the case. The guide recommends looking beyond the experience of an individual surgeon when assessing a treatment centre.
• India offers an illustrative cost advantage for the treatment scope described in the guide. The stated range is approximately US$3,000–15,000 in India, compared with US$20,000–55,000 in the UK and US$65,000–150,000+ in the United States. Advanced disease, reconstruction and systemic therapies can increase the final cost.
• Patients should compare complete treatment estimates rather than surgery prices alone. The guide recommends checking whether surgery, reconstruction, pathology, molecular testing, radiotherapy, hospitalisation and rehabilitation are included, while recognising that chemotherapy, targeted therapy and immunotherapy may be additional ongoing expenses.
• The guide recommends planning the cancer-treatment journey before travelling from Bangladesh to India. Patients can begin with remote review of biopsy and imaging reports, followed by a hospital treatment estimate, medical-visa documentation, staging and tumour-board review, treatment and recovery. Surgery alone may require approximately three to four weeks away from home, while radiotherapy may extend the stay to five or six weeks.
• Long-term follow-up should be arranged before returning to Bangladesh. The Indian treatment team can provide a written treatment summary and surveillance plan so that ongoing treatment or monitoring can continue with an oncologist in Bangladesh, with communication between the teams where appropriate.

Quick Facts

Treatment

Cancer Treatment and Surgery

Country

India

Patients

Bangladeshi Patients

Key Specialists

Surgical Oncologist, Medical Oncologist, Radiation Oncologist & Pathologist

Treatment Options

Surgery, Radiotherapy, Chemotherapy, Targeted Therapy & Immunotherapy

Key Concern

Oral Cancer and Betel Quid / Smokeless Tobacco Exposure

Key Assessment

Cancer Type, Stage & Tumour Biology

Multidisciplinary Care

Tumour Board Review

Reconstructive Care

Important for Selected Oral and Head-and-Neck Cancers

India Cost

US$3,000–15,000

UK Cost

US$20,000–55,000

US Cost

US$65,000–150,000+

Surgery Stay

Approximately 15–25 Days Away From Home

Overall Stay

About 3–4 Weeks for Surgery; 5–6 Weeks With Radiotherapy

Pre-Travel Planning

Biopsy / Imaging Review & Written Estimate

Visa

Indian Medical Visa

Follow-Up

Continued Oncology Care and Surveillance in Bangladesh

Key Financial Check

Itemised Treatment Estimate

Key Selection Factor

Multidisciplinary Cancer Team

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

In Brief

Cancer treatment in India for Bangladeshi patients may involve surgery, radiotherapy, chemotherapy, targeted therapy or immunotherapy depending on the cancer type, stage and tumour biology. The guide particularly emphasises multidisciplinary tumour-board review, reconstructive capability for oral and head-and-neck cancers, advanced radiotherapy and molecular testing, transparent cost estimates and coordinated international-patient care. For the treatment scope described, the guide gives an illustrative cost range of US$3,000–15,000 in India. Patients should review medical records before travel, arrange the appropriate medical visa, plan accommodation and companion costs, and establish a clear pathway for continued treatment and cancer surveillance after returning to Bangladesh.

What Cancer Treatment and Surgery Actually Involves

Cancer treatment is rarely just an operation, and the right combination depends on the cancer type, its stage, and its specific biology. Oncologists generally draw on:

• Surgery — removing the tumour and, where needed, nearby lymph nodes, sometimes combined with reconstructive surgery in the same operation to restore appearance and function, particularly important for oral and head-and-neck cancers.
• Radiotherapy — external beam radiation delivered over a course of sessions, or brachytherapy, where a radioactive source is placed directly at the tumour site.
• Chemotherapy, targeted therapy and immunotherapy — systemic treatments chosen based on the cancer's stage and, increasingly, on molecular testing of the tumour itself.
• Multidisciplinary tumour board review — where a surgical oncologist, medical oncologist, radiation oncologist and pathologist jointly agree on a treatment sequence, rather than one specialist deciding alone.

Ask for the exact stage of the cancer, the specific treatment sequence being proposed, and whether the plan has been reviewed by a full multidisciplinary tumour board rather than by a single surgeon.

Why the Regional Disease Pattern Matters for Treatment Planning

Because betel quid and smokeless tobacco use is woven into everyday social life in Bangladesh — and the Dhaka study found the risk of oral cancer in women who use it can be many times higher than in women who do not — many patients and their families do not connect the habit to the disease until a diagnosis is already made. This has two practical consequences for treatment planning. First, a mouth ulcer, white or red patch, or persistent soreness in a habitual betel quid user deserves prompt specialist evaluation, not reassurance that it will heal on its own. Second, because oral cancer often involves visible, function-critical areas of the face and mouth, the surgical plan should address reconstruction — how the patient will look, eat and speak afterward — from the outset, not as an afterthought once the tumour has been removed.

Why India Specifically for Cancer Treatment?

India has become the most common destination for Bangladeshi patients seeking cancer treatment abroad. Peer-reviewed research surveying patients directly at the Indian Visa Application Centre in Chittagong found that oncology is among the most common reasons for the trip, and that the decision consistently comes down to a combination of experienced specialist teams, hospital quality and cost. Several practical advantages reinforce this pattern for cancer care specifically:

• Deep experience with the exact cancers common in this region. India's own high burden of betel-quid-related oral cancer means its leading cancer centres have unusually extensive experience diagnosing and surgically treating it, including complex reconstructive techniques.
• Integrated multidisciplinary tumour boards in larger centres in Kolkata, Chennai, Delhi and Mumbai, combining surgical oncology, medical oncology, radiation oncology and pathology under one coordinated plan.
• Access to microvascular reconstructive surgery, advanced radiotherapy technology, and molecular tumour testing, which increasingly determines whether targeted therapy will genuinely benefit a specific patient.
• Easy connectivity and an established medical-visa system built specifically around Bangladeshi patients, including a dedicated government portal for hospital invitation letters and provision for up to three accompanying attendants.

Complete Cancer Treatment: Cost Range by Country

Surgery + radiotherapy where indicated, illustrative range, 2026

What the Numbers Actually Mean

The headline number matters less than what it includes. A Bangladeshi patient comparing quotes should ask each Indian hospital to confirm whether the figure covers surgery and any reconstruction, the number of radiotherapy sessions, pathology and molecular testing, the full hospital stay rather than just the operating theatre fee, and post-operative rehabilitation such as speech or swallowing therapy after oral cancer surgery. Chemotherapy, targeted therapy or immunotherapy, when indicated, is almost always a separate, ongoing cost.

Peer-reviewed research on cross-border medical travel found that international patients spend an average of 3,800 to 7,000 US dollars per visit once transport, accommodation and incidental costs are added to treatment itself — a range worth budgeting for on top of the treatment cost shown above. How long a patient stays in India depends heavily on whether radiotherapy is completed there or continued at home: surgery alone typically needs 15 to 25 days away; a full radiotherapy course added on can extend this to five or six weeks.

Most Bangladeshi patients follow a broadly similar sequence, whether they travel independently or through a medical-facilitation service. Knowing the shape of it in advance makes each step easier to plan for.

Factors a Bangladeshi Patient Should Weigh Before Cancer Treatment in India

Beyond the surgery itself, the decisions that most affect a patient's experience are logistical and financial rather than purely medical. Consider each of the following before confirming a hospital:

• Which city, not just which hospital. Kolkata is closest and most familiar linguistically; Chennai, Delhi and Mumbai often have a wider choice of dedicated cancer centres. Weigh travel time and cost against the depth of the care team.
• A genuine multidisciplinary tumour board — not the operating surgeon's case volume alone. Ask directly whether a medical oncologist, radiation oncologist and pathologist all review the case together.
• Reconstructive surgical capability, particularly for oral and head-and-neck cancers, confirmed as part of the surgical plan from the outset.
• Genuine hospital accreditation. Ask whether the hospital holds NABH or JCI accreditation and verify it directly through the accreditation board's own directory rather than taking a brochure's word for it.
• An itemised, written estimate covering surgery, reconstruction, pathology, and the number of radiotherapy or chemotherapy sessions included.
• Medical visa documentation. A formal invitation letter from the treating hospital, submitted through India's official medical-visa channel, is required at the Indian visa centre in Dhaka, Chittagong, Sylhet or Rajshahi.
• A travel companion. Indian hospitals generally expect at least one attendant to stay with the patient; factor their stay, food and local transport into the budget.
• A written long-term surveillance plan, since cancer follow-up is measured in years, not weeks — agree in advance who monitors for recurrence once the patient is home.

Before You Book: A Checklist for Cancer Treatment in India

A Closing Words

For most Bangladeshi families, India offers a genuine value proposition for cancer treatment: deep experience with the specific cancers common in this region, an integrated team working from one coordinated plan, and access to reconstructive and radiotherapy technology, at a fraction of the cost charged in the UK or US. The value, however, depends entirely on the specifics: confirmation that a full multidisciplinary team, not one surgeon, has reviewed the case, a transparent itemised estimate, and a realistic plan for where treatment and long-term surveillance continue once the patient is back home. Patients who ask detailed questions before booking, rather than after arriving, consistently report a smoother experience — medically and financially.

Sources

• 🌐 National Medical Commission of India — statutory body for verifying a doctor's registration and specialist qualifications. · nmc.org.in
• 🌐 National Accreditation Board for Hospitals & Healthcare Providers (NABH) — India's principal healthcare accreditation authority, under the Quality Council of India. · nabh.co
• 🌐 Smokeless Tobacco Usage and Oral Cancer Risk: A Hospital-Based Case-Control Study From Bangladesh. Peer-reviewed study, hosted via NIH/NCBI, on betel quid and smokeless tobacco as drivers of oral cancer in Bangladesh. · ncbi.nlm.nih.gov/pmc/articles/PMC12495209
• 🌐 Determinants of Bangladeshi patients' decision-making process and satisfaction toward medical tourism in India. Peer-reviewed study, hosted via NIH/NCBI. · pmc.ncbi.nlm.nih.gov/articles/PMC10185743
• 🌐 Government of India — Medical Value Travel / e-Medical Visa Portal, Bureau of Immigration, Ministry of Home Affairs — official channel for hospital invitation letters and medical-visa provisions for Bangladeshi nationals. · indianfrro.gov.in/frro/medicalvaluetravel

Frequently Asked Questions by Bangladeshi Patients about Cancer Treatment and Surgery in India

What cancer treatments are available in India for Bangladeshi patients?

Treatment may include surgery, radiotherapy, chemotherapy, targeted therapy and immunotherapy. The appropriate combination depends on the cancer type, stage and tumour biology.

How much does cancer treatment cost in India for Bangladeshi patients?

The guide provides an illustrative range of US$3,000–15,000 for the treatment scope described. Actual costs vary according to cancer type, stage, surgery, reconstruction and additional therapies.

Why is a multidisciplinary tumour board important for cancer treatment?

A tumour board allows surgical, medical and radiation oncologists and pathologists to review the case together. This helps establish a coordinated treatment sequence rather than relying on one specialist alone.

Is reconstructive surgery important for oral cancer patients?

It can be important when cancer surgery affects areas involved in appearance, eating or speech. The guide recommends discussing reconstruction as part of the initial treatment plan rather than arranging it later.

How long should Bangladeshi patients stay in India for cancer surgery?

The guide indicates that surgery-based treatment may require approximately 15–25 days away from home, with the overall journey commonly planned around three to four weeks. Radiotherapy may extend the stay to five or six weeks.

Can radiotherapy or chemotherapy continue in Bangladesh?

The guide indicates that ongoing treatment may be coordinated with an oncologist in Bangladesh. Patients should establish this arrangement with the Indian team before returning home.

What should a cancer treatment quotation from an Indian hospital include?

Patients should ask for an itemised estimate covering surgery, reconstruction where required, pathology, radiotherapy, hospitalisation and relevant rehabilitation. Additional systemic therapies should also be clarified.

Do Bangladeshi patients need a medical visa for cancer treatment in India?

Yes. Patients travelling to India for treatment need the appropriate medical-visa documentation, including supporting documentation from the treating hospital. Accompanying attendants require the relevant documentation as well.

What should Bangladeshi patients check before choosing an Indian cancer hospital?

They should assess specialist experience, multidisciplinary tumour-board availability, reconstructive capability where relevant, hospital accreditation, treatment costs, medical-visa support and long-term follow-up arrangements.

How should cancer follow-up be managed after returning to Bangladesh?

Patients should return home with a written treatment summary and surveillance plan. Continued oncology care and monitoring can then be coordinated with the treating team in Bangladesh, with communication with the Indian team where appropriate.

Page Summary

This guide helps Bangladeshi patients understand and plan cancer treatment and surgery in India, covering surgery, radiotherapy, chemotherapy, targeted therapy and immunotherapy. It gives particular attention to oral cancer, reconstructive surgery, multidisciplinary tumour-board review and the practical factors that should be assessed before selecting an Indian cancer centre. The guide provides an illustrative treatment-cost comparison of US$3,000–15,000 in India, compared with higher ranges presented for the UK and United States. It also explains the typical journey from remote medical-record review and treatment estimation through medical-visa preparation, staging, tumour-board assessment, treatment, recovery and long-term follow-up in Bangladesh.

Citation Block

Field	Information
Topic	Cancer Treatment and Surgery in India
Treatment	Cancer Surgery, Radiotherapy, Chemotherapy, Targeted Therapy & Immunotherapy
Country	India
Patients	Bangladeshi Patients
Key Specialists	Surgical Oncologist, Medical Oncologist, Radiation Oncologist & Pathologist
Treatment Selection	Cancer Type, Stage and Tumour Biology
Surgical Care	Tumour Removal, Lymph-Node Surgery and Reconstruction Where Required
Oral Cancer Care	Surgical Oncology With Reconstructive Planning for Selected Patients
Radiotherapy	External-Beam Radiotherapy and Brachytherapy
Systemic Treatment	Chemotherapy, Targeted Therapy and Immunotherapy
Multidisciplinary Care	Surgical Oncology, Medical Oncology, Radiation Oncology and Pathology
Tumour Board	Recommended for Coordinated Treatment Planning
Hospital Quality	NABH / JCI Accreditation Should Be Verified
India Cost	US$3,000–15,000
UK Cost	US$20,000–55,000
US Cost	US$65,000–150,000+
Treatment Expenses	Surgery, Reconstruction, Pathology, Radiotherapy, Hospitalisation and Rehabilitation Where Applicable
Pre-Travel Assessment	Biopsy, Imaging and Medical Records Reviewed Before Travel
Travel Planning	Medical Visa, Hospital Invitation, Accommodation and Travel Companion
Overall Stay	Approximately 3–4 Weeks for Surgery; 5–6 Weeks With Radiotherapy
Follow-Up	Written Treatment Summary and Long-Term Surveillance in Bangladesh
Key Selection Factor	Integrated Multidisciplinary Cancer Team Rather Than Surgeon Alone
Warning Sign	Treatment Planned Without Adequate Multidisciplinary Review